Literature DB >> 7912021

Serological and nucleic acid analyses for HIV and HTLV infection on archival human plasma samples from Zaire.

D K Dube1, S Dube, S Erensoy, B Jones, V Bryz-Gornia, T Spicer, J Love, N Saksena, M F Lechat, D I Shrager.   

Abstract

In order to better understand the genomic diversity and molecular phylogeny of the human retroviruses, the plasmas from 250 Zairean patients collected in 1969 were tested for antibodies to human T-cell lymphoma and human immunodeficiency viruses (HTLV or HIV) using ELISA and confirmatory Western blots and for viral nucleic acids by reverse transcriptase-directed PCR (RT-PCR). Interestingly, none of the patients was confirmed positive for HIV, even though this region is now endemic for HIV-1. However, 74 (30%) and 3 (1%) of the samples were positive for antibodies to HTLV-I and II, respectively. Forty-four of 74 (59%) Western blot-positive Zairean samples were RT-PCR positive for HTLV-I, while 1 of 3 (33%) of HTLV-II-seropositive samples was RT-PCR positive. On the contrary, none of the Western blot-negative or indeterminate samples were RT-PCR positive for either HTLV-I or HTLV-II. We have cloned and sequenced 140 bp of the pol gene flanked by SK110/SK111 from 8 HTLV-I- and 1 HTLV-II-positive archival samples from Zaire. The HTLV-I isolates from Zaire cluster together as a phylogenetic group, diverging from the prototype Japanese HTLV-I (ATK) by a range of 1.4 to 3.6%. Their close homology to some African STLV-I isolates suggests relatively recent interspecies transmission. The Zairean HTLV-II isolate is closely grouped with the HTLV-II substrain of isolates found in Paleo-Amerindians of the New World, making it unlikely that it represents an endemic African strain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7912021     DOI: 10.1006/viro.1994.1354

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Multiplex detection of four pathogenic retroviruses using molecular beacons.

Authors:  J A Vet; A R Majithia; S A Marras; S Tyagi; S Dube; B J Poiesz; F R Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

2.  Isolation and molecular characterization of a human T-cell lymphotropic virus type II (HTLV-II), subtype B, from a healthy Pygmy living in a remote area of Cameroon: an ancient origin for HTLV-II in Africa.

Authors:  A Gessain; P Mauclère; A Froment; M Biglione; J Y Le Hesran; F Tekaia; J Millan; G de Thé
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

3.  Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in Pygmies.

Authors:  R Mahieux; F Ibrahim; P Mauclere; V Herve; P Michel; F Tekaia; C Chappey; B Garin; E Van Der Ryst; B Guillemain; E Ledru; E Delaporte; G de The; A Gessain
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

Review 4.  HTLV-1 and innate immunity.

Authors:  Chloé Journo; Renaud Mahieux
Journal:  Viruses       Date:  2011-08-08       Impact factor: 5.048

5.  Delayed seroconversion to STLV-1 infection is associated with mutations in the pol and rex genes.

Authors:  Syamalima Dube; Nitin Saksena; Timothy Spicer; Jayne Healey; Patricia Benz; Dipak K Dube; Bernard J Poiesz
Journal:  Virol J       Date:  2013-09-11       Impact factor: 4.099

Review 6.  Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes.

Authors:  Philippe V Afonso; Olivier Cassar; Antoine Gessain
Journal:  Retrovirology       Date:  2019-12-16       Impact factor: 4.602

7.  Human T-cell lymphotropic virus type 1 transmission dynamics in rural villages in the Democratic Republic of the Congo with high nonhuman primate exposure.

Authors:  Megan Halbrook; Adva Gadoth; Anupama Shankar; HaoQiang Zheng; Ellsworth M Campbell; Nicole A Hoff; Jean-Jacques Muyembe; Emile Okitolonda Wemakoy; Anne W Rimoin; William M Switzer
Journal:  PLoS Negl Trop Dis       Date:  2021-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.